CAR T Cell Therapy in Glioblastoma: Overcoming Challenges Related to Antigen Expression

SIMPLE SUMMARY: Glioblastoma is the most common brain cancer, and prognosis remains dismal. Continued efforts to find better treatments have shown the promise of immunotherapy, whereby the immune response against a tumor is augmented. One particular immunotherapy, CAR T therapy, involves engineering...

Descripción completa

Detalles Bibliográficos
Autores principales: Luksik, Andrew S., Yazigi, Eli, Shah, Pavan, Jackson, Christopher M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10000604/
https://www.ncbi.nlm.nih.gov/pubmed/36900205
http://dx.doi.org/10.3390/cancers15051414

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10000604/
https://www.ncbi.nlm.nih.gov/pubmed/36900205
http://dx.doi.org/10.3390/cancers15051414

Ejemplares similares